Antiarrhythmic Drugs

1.	Antiarrhythmic Drugs
1.1.	Physiology
1.2.	Disorders of Cardiac Rhythm (Arrhythmias)
1.3.	Cardiac Action Potentials
1.4.	General Aspects of Pharmacology
1.5.	General Aspects of Chemistry
2.	Individual Antiarrhythmic Drugs
2.1.	Class I Drugs: Sodium Channel Blockers
2.1.1.	Class I a Drugs
2.1.2.	Class I b Drugs
2.1.3.	Class I c Drugs
2.2.	Class II Drugs: β-Receptor Blocking Agents
2.3.	Class III Drugs: Agents Increasing the Action Potential Duration
2.4.	Class IV Drugs: Calcium Channel Blockers
2.5.	New Antiarrhythmic Drugs

References

1 H. Antoni in R. F. Schmidt, G. Thew (eds.): Human Physiology, Springer Verlag, Berlin-Heidelberg-New York 1983, pp. 358 – 396.
Google Scholar
2 A. C. Guyton: Basic Human Physiology, Saunders, Philadelphia-London-Toronto 1977.
Google Scholar
3 E. B. Mason: Human Physiology, Benjamin-Cummings Publishing Co., Menlo Park 1983.
Google Scholar
4 R. M. Berne (ed.): “The Heart”, Handbook of Physiology, Sect. 2, vol. 1, Am. Physiol. Soc., Bethesda 1979.
Google Scholar
5 R. Thorspecken, P. Hassenstein: Rhythmusstörungen des Herzens, Thieme Verlag, Stuttgart 1975.
Google Scholar
6 H. Roskamm, H. Reindell (eds.): Herzkrankheiten, Springer Verlag, Berlin-Heidelberg-New York 1982.
10.1007/978-3-642-96617-0
Google Scholar
7 B. Lüderitz (ed.): Ventrikuläre Herzrhythmusstörungen, Springer Verlag, Berlin-Heidelberg-New York 1981.
Google Scholar
8 D. T. Mason, A. N. Demaria, E. A. Amsterdam, R. Zelis, R. A. Massumi, Drugs 5 (1973) 292 – 317.
10.2165/00003495-197305040-00003
CAS Web of Science® Google Scholar
9 B. Lüderitz: „Herzrhythmusstörungen“, Handbuch der inneren Medizin, Springer Verlag, Berlin-Heidelberg-New York 1983.
Google Scholar
10 P. H. Morgan, I. W. Mathison, J. Pharm. Sci. 65 (1976) no. 4, 467.
10.1002/jps.2600650402
CAS PubMed Web of Science® Google Scholar
11 L. S. Gettes, Am. J. Cardiol. 28 (1971) 528.
10.1016/0002-9149(71)90094-4
Web of Science® Google Scholar
12 E. M. Vaughan Williams in L. Szekeres (ed.): Pharmacology of Antiarrhythmic Agents, Pergamon Press, Oxford-New York 1981, pp. 125 – 150.
Google Scholar
13 E. M. Vaughan Williams, J. Clin. Pharmacol. 24 (1984) 129 – 147.
10.1002/j.1552-4604.1984.tb01822.x
CAS PubMed Web of Science® Google Scholar
14 E. M. Vaughan Williams, Eur. Heart J. 5 (1984) 96 – 98.
10.1093/oxfordjournals.eurheartj.a061632
PubMed Web of Science® Google Scholar
15 P. Honerjäger in C.-J. Estler (ed.): Lehrbuch der allgemeinen und systematischen Pharmakologie und Toxikologie, F. K. Schattauer Verlag, Stuttgart-New York 1983, p. 236.
Google Scholar
16 R. P. Ahlquist, Am. J. Physiol. 153 (1984) 586.
PubMed Web of Science® Google Scholar
17 D. G. McDevitt, Drugs 17 (1979) 267 – 288.
10.2165/00003495-197917040-00002
CAS PubMed Web of Science® Google Scholar
18 R. E. Thomas in M. Wolff (ed.): Burger's Medical Chemistry, 4th edition, part III, Wiley & Sons, New York 1981, pp. 81 – 102.
Google Scholar
19 D. Hellenbrecht et al., Naunyn Schmiedebergs Arch. Pharmacol. 277 (1973) 211.
10.1007/BF00501161
CAS PubMed Web of Science® Google Scholar
20 D. Hellenbrecht et al., Eur. J. Pharmacol. 29 (1974) 223.
10.1016/0014-2999(74)90020-X
CAS PubMed Web of Science® Google Scholar
21 O. Kraupp in W. Forth, D. Henschler, W. Rummel (eds.): Allgemeine und spezielle Pharmakologie und Toxikologie, 4th ed., Bibliographisches Institut, Mannheim-Wien-Zürich 1983, pp. 192 – 212.
Google Scholar
22 B. N. Singh in L. Szekeres (ed.): Pharmacology of Antiarrhythmic Agents, Pergamon Press, Oxford-New York 1981, pp. 151 – 194.
Google Scholar
23 B. R. Lucchesi and E. S. Patterson in M. J. Antonaccio (ed.): Cardiovascular Pharmacology, Raven Press, New York 1984, pp. 329 – 414.
Google Scholar
24 C. Kumana, J. Hamer in J. Hamer (ed.): Drugs for Heart Disease, Chapman & Hall, London 1979, pp. 44 – 147.
Google Scholar
25 C. D. Swerdlow, J. O. Yu, E. Jacobson, S. Mann, R. A. Winkle, J. G. Griffin, D. Ross, J. W. Mason, Am. J. Med. 75 (1983) 36 – 42.
10.1016/0002-9343(83)91165-8
CAS PubMed Web of Science® Google Scholar
26 R. G. Heel, R. N. Brogden, T. M. Speight, G. S. Avery, Drugs 15 (1978) 331 – 368.
10.2165/00003495-197815050-00002
CAS PubMed Web of Science® Google Scholar
27 D. P. Zipes, P. J. Troup, Am. J. Cardiol. 41 (1978) 1005 – 1024.
10.1016/0002-9149(78)90853-6
CAS PubMed Web of Science® Google Scholar
28 A. Wirtzfeld (ed.): „ Disopyramid,“ Band III, Übersicht über die internationale Literatur 1977 – 1980, Excerpta Medica, Amsterdam 1981.
Google Scholar
29 R. W. F. Campbell in J. Coltart, D. E. Jewitt (eds.): Recent Developments in Cardiovascular Drugs, Churchill Livingstone, Edinburgh 1982, pp. 94 – 100.
Web of Science® Google Scholar
30 L. Mogensen in J. Coltart, D. E. Jewitt (eds.): Recent Developments in Cardiovascular Drugs, Churchill Livingstone, Edinburgh 1982, pp. 118 – 127.
Google Scholar
31 B. Holmes, R. N. Brogden, R. G. Heel, T. M. Speight, G. S. Avery, Drugs 26 (1983) 93 – 123.
10.2165/00003495-198326020-00001
CAS PubMed Web of Science® Google Scholar
32 E. Sandøe, D. G. Julian, J. W. Bell (eds.): “Management of ventricular tachycardia – role of mexiletine”, Proceedings of a Symposium held in Copenhagen, 25th – 27th May, 1978, Excerpta Medica, Amsterdam 1978.
Google Scholar
33 C. Y. C. Chew, J. Collett, B. N. Singh, Drugs 17 (1979) 161 – 181.
10.2165/00003495-197917030-00003
CAS PubMed Web of Science® Google Scholar
34 J. Senges, L. Ehe, Naunyn Schmiedebergs Arch. Pharmacol. 280 (1973) 253 – 264.
10.1007/BF00501350
CAS PubMed Web of Science® Google Scholar
35 H. Kleinsorge, Med. Klin. (Munich) 54 (1959) 409 – 416.
CAS PubMed Google Scholar
36 R. Bojorges, G. Pastelin, S. Sanchez-Perez, R. Mendez, E. Kabela, J. Pharmacol. Exp. Ther. 193 (1975) 182 – 193.
CAS PubMed Web of Science® Google Scholar
37 D. L. D. Keefe, R. E. Kates, D. C. Harrison, Drugs 22 (1981) 363 – 400.
10.2165/00003495-198122050-00002
CAS PubMed Web of Science® Google Scholar
38 H. Homburger, H. Antoni, Arzneim. Forsch. 24 (1974) 545 – 549.
CAS PubMed Web of Science® Google Scholar
39 E. Schaumlöffel, Med. Welt 25 (1974) 2008 – 2014.
CAS PubMed Web of Science® Google Scholar
40 W. Sziegoleit, H. W. Crodel, W. Förster, Dtsch. Gesundheitswes. 30 (1975) 2489 – 2491.
Google Scholar
41 E. Carmelit, P. A. Janssen, R. Marsboom, J. M. Van Nueten, R. Xhonneux, Arch. Int. Pharmacodyn. Ther. 231 (1978) 104 – 130.
PubMed Web of Science® Google Scholar
42 W. K. Amery, T. Aerts in A. Scriabine (ed.): New Drugs Annual – Cardiovascular Drugs, Raven Press, New York 1983, pp. 109 – 132.
Google Scholar
43 F. Bender, G. Cronheim (eds.): Flecainid: Experimentelle Befunde und klinische Erfahrungen, Fischer Verlag, Stuttgart-New York 1982.
Google Scholar
44 H. Hochrein, H.-J. Hapke, O. A. Beck (eds.): Fortschritte in der Pharmakotherapie von Herzrhythmusstörungen, I. Internat. Propafenon-Symposium, 14th and 15th November 1975, in Berlin, Fischer Verlag, Stuttgart–New York 1979.
Google Scholar
45 M. Schlepper, B. Olsson (eds.): Cardiac Arrhythmias, Proceedings 1st International Rytmonorm-Congress, Springer Verlag, Berlin-Heidelberg-New York 1983.
Google Scholar
46 J. D. Dukes, E. M. Vaughan Williams, Eur. Heart J. 5 (1984) 115 – 125.
10.1093/eurheartj/5.suppl_A.115
CAS PubMed Google Scholar
47 P. Touboul, G. Kirkorian, G. Atallah in J. Coltart, D. E. Jewitt (eds.): Recent Developments in Cardiovascular Drugs, Churchill Livingstone, Edinburgh 1982, pp. 110 – 117.
Google Scholar
48 R. S. Bexton, A. J. Camm, Pharmacol. Ther. 17 (1982) 315 – 355.
10.1016/0163-7258(82)90020-1
CAS PubMed Web of Science® Google Scholar
49 J. W. Mason, L. M. Hondeghem, B. G. Katzung, Pflügers Arch. 396 (1983) 79 – 81.
10.1007/BF00584702
CAS PubMed Web of Science® Google Scholar
50 E. Patterson, B. R. Lucchesi, Am. Heart J. 106 (1983) no. 2, 426 – 431.
10.1016/0002-8703(83)90225-9
CAS PubMed Web of Science® Google Scholar
51 G. G. Belz, F. Bender: Therapie der Herzrhythmusstörungen mit Verapamil Isoptin ^®, Fischer Verlag, Stuttgart 1974.
Google Scholar
52 B. N. Singh, G. Ellrodt, C. T. Peter, Drugs 16 (1978) 169 – 197.
10.2165/00003495-197815030-00001
Web of Science® Google Scholar
53 A. Zanchetti, D. M. Krikler: “Calcium antagonism in cardiovascular therapy: Experience with verapamil,” International Symposium Florence 2nd – 4th Oct. 1980, Excerpta Medica, Amsterdam (1981).
Google Scholar
54 A. Fleckenstein: Calcium Antagonism in Heart and Smooth Muscle, Wiley-Interscience, New York 1983.
Google Scholar
55 H. U. Lehmann, C. Taegner-Torge, E. Witt, O. A. Beck, H. Hochrein, Angiocardiology 2 (1979) 103 – 111.
Google Scholar
56 E. Winslow, K. A. Kane, J. Cardiovasc. Pharmacol. 3 (1981) 655 – 667.
10.1097/00005344-198107000-00001
CAS PubMed Web of Science® Google Scholar
57 J. M. Davy, J. F. Lainé, C. Sebag, G. Motté, Circulation 68 (1983) Suppl. III, abstr. 1241.
Google Scholar
58 F. Bender, K. Greef (eds.): „Calciumantagonisten zur Behandlung der Angina pectoris, Hypertonie und Arrhythmie,“ 1. Dilzem^® Symposium Copenhagen 25th – 27th June 1981, Excerpta Medica, Amsterdam 1982.
Google Scholar
59 A. Fleckenstein, K. Hashimoto, M. Herrmann, A. Schwartz, L. Seipel (eds.): New Calcium Antagonists, Recent Development and Prospects, Diltiazem Workshop held on May 10th, 1982 in Freiburg, Fischer Verlag, Stuttgart 1983.
Google Scholar
60 R. A. Winkle, J. W. Mason, R. E. Kates, D. C. Harrison in J. Coltart, D. E. Jewitt (eds.): Recent Developments of Cardiovascular Drugs, Churchill Livingstone, Edinburgh 1982, pp. 102 – 109.
Google Scholar
61 L. B. Mitchell, R. A. Winkle in A. Scriabine (ed.): New Drugs Annual – Cardiovascular Drugs, Raven Press, New York 1983, pp. 93 – 107.
Google Scholar
62 N. N. Kipshidze, Med. Actual 15 (1979) No. 7, 320 – 323.
Google Scholar
63 G. G. Gensini, R. F. Knope, A. E. Kelly (eds.): Concepts of the Mechanism and Treatment of Arrhythmias, Futura Publ. Company, Mount Kisco 1974.
Google Scholar
64 E. E. Bagwell, T. Walle, D. E. Drayer, M. M. Reidenberg, J. K. Pruett, J. Pharmacol. Exp. Ther. 197 (1976) 38 – 48.
CAS PubMed Web of Science® Google Scholar

Ullmann's Encyclopedia of Industrial Chemistry

Browse other articles of this reference work:

Antiarrhythmic Drugs

Abstract

References

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Antiarrhythmic Drugs

Abstract

References

References

Related

Information